Jane Street’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$522K Buy
465,820
+402,129
+631% +$450K ﹤0.01% 3655
2025
Q1
$50.3K Buy
63,691
+32,911
+107% +$26K ﹤0.01% 5295
2024
Q4
$50.8K Sell
30,780
-117,092
-79% -$193K ﹤0.01% 5485
2024
Q3
$518K Sell
147,872
-69,867
-32% -$245K ﹤0.01% 4253
2024
Q2
$714K Buy
217,739
+23,080
+12% +$75.7K ﹤0.01% 4117
2024
Q1
$1.43M Sell
194,659
-516,628
-73% -$3.79M ﹤0.01% 2746
2023
Q4
$2.66M Sell
711,287
-12,986
-2% -$48.6K ﹤0.01% 2157
2023
Q3
$1.54M Buy
724,273
+263,991
+57% +$560K ﹤0.01% 2505
2023
Q2
$2.19M Buy
460,282
+365,254
+384% +$1.74M ﹤0.01% 2327
2023
Q1
$542K Sell
95,028
-59,919
-39% -$342K ﹤0.01% 3580
2022
Q4
$1.56M Buy
154,947
+143,023
+1,199% +$1.44M ﹤0.01% 2210
2022
Q3
$267K Sell
11,924
-10,271
-46% -$230K ﹤0.01% 4319
2022
Q2
$550K Buy
+22,195
New +$550K ﹤0.01% 3461
2022
Q1
Sell
-25,235
Closed -$1.48M 5789
2021
Q4
$1.48M Buy
25,235
+9,671
+62% +$566K ﹤0.01% 2289
2021
Q3
$922K Sell
15,564
-912
-6% -$54K ﹤0.01% 2744
2021
Q2
$1.43M Sell
16,476
-24,798
-60% -$2.15M ﹤0.01% 2141
2021
Q1
$3.4M Sell
41,274
-22,214
-35% -$1.83M ﹤0.01% 1109
2020
Q4
$5.77M Buy
63,488
+19,913
+46% +$1.81M ﹤0.01% 637
2020
Q3
$1.74M Buy
43,575
+35,593
+446% +$1.42M ﹤0.01% 1317
2020
Q2
$274K Sell
7,982
-3,089
-28% -$106K ﹤0.01% 3146
2020
Q1
$246K Buy
+11,071
New +$246K ﹤0.01% 2731
2019
Q4
Sell
-15,562
Closed -$242K 3437
2019
Q3
$242K Buy
15,562
+320
+2% +$4.98K ﹤0.01% 2889
2019
Q2
$309K Buy
+15,242
New +$309K ﹤0.01% 2711
2019
Q1
Sell
-13,656
Closed -$175K 3414
2018
Q4
$175K Buy
13,656
+3,529
+35% +$45.2K ﹤0.01% 2865
2018
Q3
$165K Sell
10,127
-86
-0.8% -$1.4K ﹤0.01% 3190
2018
Q2
$116K Buy
+10,213
New +$116K ﹤0.01% 3034
2017
Q4
Sell
-11,292
Closed -$45K 3162
2017
Q3
$45K Buy
+11,292
New +$45K ﹤0.01% 2785
2014
Q3
Sell
-12,200
Closed -$77K 2334
2014
Q2
$77K Buy
12,200
+300
+3% +$1.89K ﹤0.01% 2109
2014
Q1
$116K Buy
+11,900
New +$116K ﹤0.01% 2209